Literature DB >> 16790751

Early events in Mycobacterium tuberculosis infection in cynomolgus macaques.

Philana Ling Lin1, Santosh Pawar, Amy Myers, Amarenda Pegu, Carl Fuhrman, Todd A Reinhart, Saverio V Capuano, Edwin Klein, Joanne L Flynn.   

Abstract

Little is known regarding the early events of infection of humans with Mycobacterium tuberculosis. The cynomolgus macaque is a useful model of tuberculosis, with strong similarities to human tuberculosis. In this study, eight cynomolgus macaques were infected bronchoscopically with low-dose M. tuberculosis; clinical, immunologic, microbiologic, and pathologic events were assessed 3 to 6 weeks postinfection. Gross pathological abnormalities were observed as early as 3 weeks, including Ghon complex formation by 5 weeks postinfection. Caseous granulomas were observed in the lung as early as 4 weeks postinfection. Only caseous granulomas were observed in the lungs at these early time points, reflecting a rigorous initial response. T-cell activation (CD29 and CD69) and chemokine receptor (CXCR3 and CCR5) expression appeared localized to different anatomic sites. Activation markers were increased on cells from airways and only at modest levels on cells in peripheral blood. The priming of mycobacterium-specific T cells, characterized by the production of gamma interferon occurred slowly, with responses seen only after 4 weeks of infection. These responses were observed from T lymphocytes in blood, airways, and hilar lymph node, with responses predominantly localized to the site of infection. From these studies, we conclude that immune responses to M. tuberculosis are relatively slow in the local and peripheral compartments and that necrosis occurs surprisingly quickly during granuloma formation.

Entities:  

Mesh:

Year:  2006        PMID: 16790751      PMCID: PMC1489679          DOI: 10.1128/IAI.00064-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Improved detection of simian immunodeficiency virus RNA by in situ hybridization in fixed tissue sections: combined effects of temperatures for tissue fixation and probe hybridization.

Authors:  Beth A Fallert; Todd A Reinhart
Journal:  J Virol Methods       Date:  2002-01       Impact factor: 2.014

2.  CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection.

Authors:  Vanja Lazarevic; Amy J Myers; Charles A Scanga; JoAnne L Flynn
Journal:  Immunity       Date:  2003-12       Impact factor: 31.745

3.  Value of combining the erythrocyte sedimentation rate test with tuberculin testing in the control of tuberculosis in baboons.

Authors:  G W Tribe; A E Welburn
Journal:  Lab Anim       Date:  1976-01       Impact factor: 2.471

4.  Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis.

Authors:  M I Sadek; E Sada; Z Toossi; S K Schwander; E A Rich
Journal:  Am J Respir Cell Mol Biol       Date:  1998-09       Impact factor: 6.914

5.  Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth.

Authors:  Jussi J Saukkonen; Beth Bazydlo; Michael Thomas; Robert M Strieter; Joseph Keane; Hardy Kornfeld
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

6.  Evidence for a rhesus monkey model of asymptomatic tuberculosis.

Authors:  Bobby J Gormus; James L Blanchard; Xavier H Alvarez; Peter J Didier
Journal:  J Med Primatol       Date:  2004-06       Impact factor: 0.667

7.  Chemokine response in mice infected with Mycobacterium tuberculosis.

Authors:  E R Rhoades; A M Cooper; I M Orme
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

8.  Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and nonpulmonary tuberculosis.

Authors:  Simon M Barry; Marc C Lipman; Barbara Bannister; Margaret A Johnson; George Janossy
Journal:  J Infect Dis       Date:  2002-12-19       Impact factor: 5.226

9.  TNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during Mycobacterium tuberculosis infection.

Authors:  Holly M Scott Algood; Philana Ling Lin; David Yankura; Alvin Jones; John Chan; JoAnne L Flynn
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

10.  THE CORRELATION BETWEEN THE HISTOLOGICAL CHANGES AND THE FATE OF LIVING TUBERCLE BACILLI IN THE ORGANS OF TUBERCULOUS RABBITS.

Authors:  M B Lurie
Journal:  J Exp Med       Date:  1932-01-01       Impact factor: 14.307

View more
  119 in total

1.  Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection.

Authors:  Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; JoAnne L Flynn; Denise E Kirschner
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing.

Authors:  S A Sharpe; H McShane; M J Dennis; R J Basaraba; F Gleeson; G Hall; A McIntyre; K Gooch; S Clark; N E R Beveridge; E Nuth; A White; A Marriott; S Dowall; A V S Hill; A Williams; P D Marsh
Journal:  Clin Vaccine Immunol       Date:  2010-06-09

3.  CD4 T cell depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent infection is dependent on severity of tissue depletion in cynomolgus macaques.

Authors:  Philana Ling Lin; Tara Rutledge; Angela M Green; Matthew Bigbee; Carl Fuhrman; Edwin Klein; JoAnne L Flynn
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-04       Impact factor: 2.205

4.  Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model.

Authors:  Philana Ling Lin; Amy Myers; Le'Kneitah Smith; Carolyn Bigbee; Matthew Bigbee; Carl Fuhrman; Heather Grieser; Ion Chiosea; Nikolai N Voitenek; Saverio V Capuano; Edwin Klein; JoAnne L Flynn
Journal:  Arthritis Rheum       Date:  2010-02

5.  Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis.

Authors:  Jia Yao Phuah; Joshua T Mattila; Philana L Lin; JoAnne L Flynn
Journal:  Am J Pathol       Date:  2012-06-19       Impact factor: 4.307

6.  Pulmonary Mycobacterium tuberculosis control associates with CXCR3- and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment.

Authors:  Uma Shanmugasundaram; Allison N Bucsan; Shashank R Ganatra; Chris Ibegbu; Melanie Quezada; Robert V Blair; Xavier Alvarez; Vijayakumar Velu; Deepak Kaushal; Jyothi Rengarajan
Journal:  JCI Insight       Date:  2020-07-23

7.  Antigen-specific Vgamma2Vdelta2 T effector cells confer homeostatic protection against pneumonic plaque lesions.

Authors:  Dan Huang; Crystal Y Chen; Zahida Ali; Lingyun Shao; Ling Shen; Hank A Lockman; Roy E Barnewall; Carol Sabourin; James Eestep; Armin Reichenberg; Martin Hintz; Hassan Jomaa; Richard Wang; Zheng W Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

8.  Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis.

Authors:  Grant Theron; Jason Limberis; Rouxjeane Venter; Liezel Smith; Elize Pietersen; Aliasgar Esmail; Greg Calligaro; Julian Te Riele; Marianna de Kock; Paul van Helden; Tawanda Gumbo; Taane G Clark; Kevin Fennelly; Robin Warren; Keertan Dheda
Journal:  Nat Med       Date:  2020-06-29       Impact factor: 53.440

9.  A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment.

Authors:  Elsje Pienaar; Nicholas A Cilfone; Philana Ling Lin; Véronique Dartois; Joshua T Mattila; J Russell Butler; JoAnne L Flynn; Denise E Kirschner; Jennifer J Linderman
Journal:  J Theor Biol       Date:  2014-12-09       Impact factor: 2.691

Review 10.  CD8 T cells and Mycobacterium tuberculosis infection.

Authors:  Philana Ling Lin; JoAnne L Flynn
Journal:  Semin Immunopathol       Date:  2015-04-28       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.